Insider · CIK 0001266802

JACOB GARY S

Reports to the SEC for 6 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001266802

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-21	OKYOOKYO Pharma LtdP Purchase	Director, CHIEF DEVELOPMENT OFFICER	PPurchase	+3,500 sh	$1.40	+$4,900	112,420
2026-07-21	OKYOOKYO Pharma LtdA Award	Director, CHIEF DEVELOPMENT OFFICER	AAward	+3,500 sh	$1.40	+$4,900	112,420
2024-02-19	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director	AAward	+85K sh	—	—	102,120
2022-05-19	OKYOOKYO Pharma LtdP Purchase	Director, CHIEF DEVELOPMENT OFFICER	PPurchase	+12.5K sh	$4.00	+$50K	12,500
2022-01-01	Virpax Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.1K sh	—	—	12,091
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+755 sh	—	—	76,106
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+218 sh	—	—	76,106
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+223 sh	—	—	76,106
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+223 sh	—	—	76,106
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+530 sh	—	—	76,106
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+44.7K sh	—	—	76,106
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+28.9K sh	—	—	76,106
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+293 sh	—	—	76,106
2021-05-18	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director	AAward	+250K sh	—	—	342,785
2021-04-07	Virpax Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+13.2K sh	—	—	13,183
2021-03-23	CRDFCardiff Oncology, Inc.P Purchase	Former Director	PPurchase	+1,900 sh	$10.42	+$19.8K	21,452
2021-03-23	CRDFCardiff Oncology, Inc.P Purchase	Former Director	PPurchase	+470 sh	$10.39	+$4,885.65	21,922
2021-02-17	Virpax Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+3,500 sh	$6.79	+$23.8K	3,500
2020-12-01	HEPAHepion Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+12K sh	$1.66	+$19.9K	12,059
2020-08-19	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director	AAward	+30K sh	—	—	92,785
2020-06-17	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+28.9K sh	—	—	76,106
2020-05-14	CRDFCardiff Oncology, Inc.P Purchase	Former Director	PPurchase	+17.5K sh	$1.43	+$25K	19,552
2020-04-03	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director	AAward	+60K sh	—	—	62,729
2019-07-24	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director	AAward	+970 sh	—	—	2,729
2019-06-20	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+44.7K sh	—	—	48,071
2018-07-03	HEPAHepion Pharmaceuticals, Inc. · WarrantsP Purchase	Director	PPurchase	+8,625 sh	$1000.00	+$8.63M	8,625
2018-07-03	HEPAHepion Pharmaceuticals, Inc. · Series C Convertible Preferred StockP Purchase	Director	PPurchase	+15 sh	$1000.00	+$15K	15
2018-06-15	SYNERGY PHARMACEUTICALS LLCM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+475K sh	$0.50	+$237K	877,640
2018-06-15	SYNERGY PHARMACEUTICALS LLCF Tax Payment	Director, Executive Chairman	FTax Payment	−132K sh	—	—	745,706
2018-06-15	SYNERGY PHARMACEUTICALS LLCF Tax Payment	Director, Executive Chairman	FTax Payment	−150K sh	—	—	595,460
2018-06-15	SYNERGY PHARMACEUTICALS LLCStock OptionsM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−475K sh	—	—	6,513,342
2018-01-23	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+54.3K sh	—	—	248,101
2018-01-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Former Director	MExercise/Conversion	+16.7K sh	—	—	148,954
2018-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Former Director	MExercise/Conversion	−16.7K sh	—	—	0
2017-10-04	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+38.1K sh	—	—	193,779
2017-09-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Former Director	MExercise/Conversion	+9,287 sh	—	—	132,287
2017-09-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Former Director	MExercise/Conversion	−9,287 sh	—	—	16,667
2017-06-28	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director, Executive Chairman	AAward	+900K sh	—	—	6,038,303
2017-06-28	SYNERGY PHARMACEUTICALS LLCStock OptionsD Disposition to Issuer	Director, Executive Chairman	DDisposition to Issuer	−900K sh	—	—	5,138,202
2017-05-26	SYNERGY PHARMACEUTICALS LLCP Purchase	Director, Executive Chairman	PPurchase	+5,680 sh	$3.52	+$20K	402,679
2017-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsA Award	Former Director	AAward	+16.7K sh	—	—	16,667
2017-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsA Award	Former Director	AAward	+16.7K sh	—	—	16,667
2017-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsA Award	Former Director	AAward	+9,287 sh	—	—	25,954
2016-07-19	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director	AAward	+65K sh	—	—	1,015,000
2016-06-24	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director, Executive Chairman	AAward	+970K sh	—	—	5,905,177
2016-01-04	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+16K sh	—	—	155,673
2015-09-29	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director, Executive Chairman	AAward	+500K sh	—	—	4,935,177
2015-07-24	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director, Executive Chairman	AAward	+300K sh	—	—	4,435,177
2015-07-01	SYNERGY PHARMACEUTICALS LLCM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+63K sh	$5.61	+$353K	396,999
2015-07-01	SYNERGY PHARMACEUTICALS LLCStock OptionsM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−63K sh	—	—	4,135,177

Recent filings

Accepted (ET)
Aug 74/A
JACOB GARY S0001493152-26-036583
SEC(opens sec.gov)
Jul 234
JACOB GARY S0001493152-26-034406
SEC(opens sec.gov)
Feb 214
JACOB GARY S0001493152-24-007462
SEC(opens sec.gov)
May 194
JACOB GARY S0001493152-22-014438
SEC(opens sec.gov)
Jan 54
JACOB GARY S0000905718-22-000024
SEC(opens sec.gov)
Jun 154
JACOB GARY S0001628280-21-012225
SEC(opens sec.gov)
May 204
JACOB GARY S0001104659-21-069940
SEC(opens sec.gov)
Apr 94
JACOB GARY S0000905718-21-000570
SEC(opens sec.gov)
Mar 234
JACOB GARY S0001628280-21-005358
SEC(opens sec.gov)
Feb 194
JACOB GARY S0001213900-21-010660
SEC(opens sec.gov)
Dec 14
JACOB GARY S0001104659-20-131213
SEC(opens sec.gov)
Aug 214
JACOB GARY S0001104659-20-097593
SEC(opens sec.gov)

Companies

Address

14-15 CONDUIT ST

LONDON, W1S 2XJ